Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes

Po-Yi Liu, Chao-Kuei Shih, Miyuki Hsing-Chun Hsieh, Ching-Chun Lin, Chieh-Yen Liu, Edward Chia-Cheng Lai, Chung-Yi Li, Chih-Hen Yu, Junne-Ming Sung · 2026

Read Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes by Po-Yi Liu, Chao-Kuei Shih, Miyuki Hsing-Chun Hsieh, Ching-Chun Lin, Chieh-Yen Liu, Edward Chia-Cheng Lai, Chung-Yi Li, Chih-Hen Yu, Junne-Ming Sung (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526834.txt.

Description

Liu and co-authors emulate a clinical trial from health records, in this 2026 study. The population is neglected: diabetic patients on dialysis for end-stage kidney disease who also have heart failure. Such patients are routinely excluded from randomized trials. Using the TriNetX records network with a new-user design and matched comparisons, they contrasted starting a GLP-1 receptor agonist against starting a DPP-4 inhibitor, two diabetes drug classes.

The GLP-1 drugs won clearly. The combined outcome of ischemic cardiovascular events and heart failure flare-ups occurred in 31.7 percent of GLP-1 starters versus 41.4 percent on the comparator, a hazard ratio of 0.72 in the matched analysis, and all-cause mortality also fell, with a hazard ratio of 0.68 in the same model. A second, more strictly defined dialysis population reproduced the benefit. The authors call for a real randomized trial while offering this as the best current evidence for these patients.

Catalog record

CREATORPo-Yi Liu, Chao-Kuei Shih, Miyuki Hsing-Chun Hsieh, Ching-Chun Lin, Chieh-Yen Liu, Edward Chia-Cheng Lai, Chung-Yi Li, Chih-Hen Yu, Junne-Ming Sung
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13526834

Browse the full library · About the Tower of Babel